Keywords: genentech, rinat, co-develop, pain, ab, neuroscience, privately-held
Genentech and Rinat to co-develop pain Ab
Article | 15 November 2004
Rinat Neuroscience, a privately-held biotechnology company, says that fellow US firm Genentech has exercised its option to co-develop and commercialize ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
